Skip to main content
Have a personal or library account? Click to login
Characteristics and Analysis of Gut Microbiota in Sepsis-associated Acute Kidney Injury Cover

Characteristics and Analysis of Gut Microbiota in Sepsis-associated Acute Kidney Injury

Open Access
|Sep 2026
Read online

References

  1. Corte-Iglesias V, Saiz ML, Andrade-Lopez AC, Salazar N, Ruiz Bernet C, Martin-Martin C, Martinez Borra J-J, Lozano J-J, Aransay AM, Diaz-Corte C, et al. 2024. Propionate and butyrate counteract renal damage and progression to chronic kidney disease. Nephrol Dial Transplant. 40(1):133–150. https://doi.org/10.1093/ndt/gfae118
  2. Evenepoel P, Poesen R, Meijers B. 2017. The gut-kidney axis. Pediatr Nephrol. 32(11):2005–2014. https://doi.org/10.1007/s00467-016-3527-x
  3. Fiorentino M, Philippe R, Palumbo CA, Prenna S, Cantaluppi V, De Rosa S. 2024. Epigenetic mechanisms in sepsis-associated acute kidney injury. Semin Respir Crit Care Med. 45(4):491–502. https://doi.org/10.1055/s-0044-1789240
  4. Gao T, Nong Z, Luo Y, Mo M, Chen Z, Yang Z, Pan L. 2024. Machine learning-based prediction of in-hospital mortality for critically ill patients with sepsis-associated acute kidney injury. Ren Fail. 46(1):2316267. https://doi.org/10.1080/0886022X.2024.2316267
  5. Huai J, Ye X. 2025. Dissecting causal relationships between gut microbiota, inflammatory factors, and acute kidney injury: a Mendelian randomization study. Clin Nephrol. 104(1):62–71. https://doi.org/10.5414/CN111632
  6. Kong J, Yang J, He C, Zhou B, Fang S, Salinas M, Mohabbat AB, Bauer BA, Wang X. 2024. Regulation of endotoxemia through the gut microbiota: the role of the Mediterranean diet and its components. APMIS. 132(12):948–955. https://doi.org/10.1111/apm.13473
  7. Kounatidis D, Tzivaki I, Daskalopoulou S, Daskou A, Adamou A, Rigatou A, Sdogkos E, Karampela I, Dalamaga M, Vallianou NG. 2024. Sepsis-associated acute kidney injury: what’s new regarding its diagnostics and therapeutics? Diagnostics (Basel). 14(24):2845. https://doi.org/10.3390/diagnostics14242845
  8. Kullberg RFJ, Haak BW, Chanderraj R, Prescott HC, Dickson RP, Wiersinga WJ. 2025. Empirical antibiotic therapy for sepsis: save the anaerobic microbiota. Lancet Respir Med. 13(1):92–100. https://doi.org/10.1016/S2213-2600(24)00257-1
  9. Lan T, Tang T, Li Y, Duan Y, Yuan Q, Liu W, Ren Y, Li N, Liu X, Zhang Y, et al. 2023. FTZ polysaccharides ameliorate kidney injury in diabetic mice by regulating gut-kidney axis. Phytomedicine. 118:154935. https://doi.org/10.1016/j.phymed.2023.154935
  10. Li Q, Song XC, Li K, Wang J. 2025. Gut-lung immunometabolic crosstalk in sepsis: from microbiota to respiratory failure. Front Med (Lausanne). 12:1685044. https://doi.org/10.3389/fmed.2025.1685044
  11. Liu AB., Tan B, Yang P, Tian N, Li JK., Wang SC., Yang LS., Ma L, Zhang JF. 2024. The role of inflammatory response and metabolic reprogramming in sepsis-associated acute kidney injury: mechanistic insights and therapeutic potential. Front. Immunol. 15:1487576. https://doi.org/10.3389/fimmu.2024.1487576
  12. Liu W, Zhang Y, Hu D, Huang L, Liu X, Lu Z 2024. Oral astragalus polysaccharide alleviates adenine-induced kidney injury by regulating gut microbiota-short-chain fatty acids-kidney G protein-coupled receptors axis. Ren. Fail. 46(2):2429693. https://doi.org/10.1080/0886022X.2024.2429693
  13. Luo Y, Gao J, Su X, Li H, Li Y, Qi W, Han X, Han J, Zhao Y, Zhang A, et al. 2025. Unraveling the immunological landscape and gut microbiome in sepsis: a comprehensive approach to diagnosis and prognosis. EBioMedicine 113:105586. https://doi.org/10.1016/j.ebiom.2025.105586
  14. Luther T, Bülow-Anderberg S, Persson P, Franzén S, Skorup P, Wernerson A, Hultenby K, Palm F, Schiffer TA., Frithiof R 2023. Renal mitochondrial dysfunction in ovine experimental sepsis-associated acute kidney injury. Am. J. Physiol. Renal Physiol. 324(6):F571–F580. https://doi.org/10.1152/ajprenal.00294.2022
  15. Mali N, Mali S, Zhang L, Fu P 2025. Interplay between gut microbiota and acute kidney injury: a review of their mutual influence and causation. Ren. Fail. 47(1):2522976. https://doi.org/10.1080/0886022X.2025.2522976
  16. Noel S, Patel SK., White J, Verma D, Menez S, Raj D, Parikh C, Rabb H, Kidney Precision Medicine Project 2025. Metagenomic profiling of gut microbiota in kidney precision medicine project participants with CKD and AKI. Compr. Physiol. 15(5):e70058. https://doi.org/10.1002/cph4.70058
  17. Odum JD., Hasson DC., Stanski NL., Gómez H, Soranno DE. 2025. The clinical view of sepsis-associated AKI: how basic science can help solve this problem. Semin. Nephrol. 45(6):151665. https://doi.org/10.1016/j.semnephrol.2025.151665
  18. Ou L, Zhu Z, Hao Y, Li Q, Liu H, Chen Q, Peng C, Zhang C, Zou Y, Jia J, et al. 2024. 1,3,6-trigalloylglucose: a novel potent anti-Helicobacter pylori adhesion agent derived from aqueous extracts of Terminalia chebula Retz. Molecules 29(5):1161. https://doi.org/10.3390/molecules29051161
  19. Pahl MV., Vaziri ND. 2015. The chronic kidney disease-colonic axis. Semin. Dial. 28(5):459–463. https://doi.org/10.1111/sdi.12381
  20. Pan L, Yu H, Fu J, Hu J, Xu H, Zhang Z, Bu M, Yang X, Zhang H, Lu J, et al. 2023. Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota. Acta Pharm. Sin. B 13(4):1537–1553. https://doi.org/10.1016/j.apsb.2022.12.010
  21. Saranya GR., Viswanathan P 2023. Gut microbiota dysbiosis in AKI to CKD transition. Biomed. Pharmacother. 161:114447. https://doi.org/10.1016/j.biopha.2023.114447
  22. Shi B, Ye J, Chen W, Liao B, Gu W, Yin H, Lyu J 2025. Prognosis of critically ill patients with early and late sepsis-associated acute kidney injury: an observational study based on the MIMIC-IV. Ren. Fail. 47(1):2441393. https://doi.org/10.1080/0886022X.2024.2441393
  23. Singer M, Deutschman CS., Seymour CW., Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR., Chiche JD., Coopersmith CM., et al. 2016. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801–810. https://doi.org/10.1001/jama.2016.0287
  24. Sun X, Wei Z, Liu Y, Li F, Liu X, Ding Q, Ding Z, Liu J, Sun Q 2025. Structural features and efficacy of polysaccharide EPS22 from Klebsiella sp. S22 in mitigating cisplatin-induced acute kidney injury. Int. J. Biol. Macromol. 311(Pt 3):143944. https://doi.org/10.1016/j.ijbiomac.2025.143944
  25. Takeuchi T, Flannery AH., Liu LJ., Ghazi L, Cama-Olivares A, Fushimi K, Chen J, Huen SC., Tolwani AJ., Neyra JA. 2025. Epidemiology of sepsis-associated acute kidney injury in the ICU with contemporary consensus definitions. Crit. Care 29(1):128. https://doi.org/10.1186/s13054-025-05351-5
  26. Tanoue K, Kinoshita M, Kearney BM., Ito S, Goto H, Yamashiro A, Fukunaga T, Sato H, Mori K, Kuwata K, et al. 2025. Lipopolysaccharide preconditioning augments the antibacterial activity of renal macrophages and ameliorates acute kidney injury caused by Staphylococcus aureus bacteremia in mice. Innate Immun. 31:17534259251335770. https://doi.org/10.1177/17534259251335770
  27. Tian X, Yuan L, Zeng Y 2025. Butyrate attenuates SA-AKI by inhibiting pyroptosis via the STING-GSDMD axis. Biochem. Biophys. Res. Commun. 743:151143. https://doi.org/10.1016/j.bbrc.2024.151143
  28. Tyc O, Kraus N, Wiedemann T, Erasmus HP., Ortiz C, Vasseur J, Hourfar K, Seidl C, Mücke MM., Storf H, et al. 2025. Enterococcus faecium DNA in acute decompensated cirrhosis: a key player in inflammation and kidney dysfunction. Front. Med. (Lausanne) 12:1629210. https://doi.org/10.3389/fmed.2025.1629210
  29. Wakino S, Hasegawa K, Tamaki M, Minato M, Inagaki T 2025. Kidney-gut axis in chronic kidney disease: therapeutic perspectives from microbiota modulation and nutrition. Nutrients 17(12):1961. https://doi.org/10.3390/nu17121961
  30. Wang F, Ye J, Zhu W, Ge R, Hu C, Qian Y, Li Y, Peng Z 2024. Galectin-3 mediates endotoxin internalization and caspase-4/11 activation in tubular epithelials and macrophages during sepsis and sepsis-associated acute kidney injury. Inflammation 47(1):454–468. https://doi.org/10.1007/s10753-023-01928-w
  31. Wang FQ., Jiang HL., Cheng SL. 2012. Intestinal-renal syndrome and chronic kidney disease. Chinese Journal of Nephrology, Dialysis & Transplantation.
  32. Wang ML., Zhang YJ., Xiao H, Lu XL., Chen L, Ma ZW., Chen A, Yin Q 2025. Probiotic effects of Clostridium cellabutyricum against Pseudomonas aeruginosa infection in an antibiotic-induced gut microbial dysbiosis mouse model. Int. J. Antimicrob. Agents 66(1):107503. DOI incomplete in source: https://doi.org/10.1016/j.ijantimicag.2025
  33. Xu P 2025. Gut microbiota metabolites targeting the immune response in sepsis: mechanisms and therapies. Int. J. Gen. Med. 18:4709–4734. https://doi.org/10.2147/IJGM.S539237
  34. Zhang Q, Yang B, Li X, Zhao Y, Yang S, Ma Q, Cui L 2025. Biomarkers of cell cycle arrest, microcirculation dysfunction, and inflammation in the prediction of SA-AKI. Sci. Rep. 15(1):8023. https://doi.org/10.1038/s41598-025-92315-y
DOI: https://doi.org/10.33073/pjm-2026-026 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 306 - 318
Submitted on: Mar 9, 2026
Accepted on: Jun 21, 2026
Published on: Sep 30, 2026
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Huaqing Liu, Wei Zhang, Yinghui Tian, Dawei Wang, Fei Liu, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.